logo
food for the brain

Championing optimum nutrition for the mind


Cochrane Review of essential fatty acids for schizophrenia inconclusive but recommends more research needed. Joy C et al, Cochrane Database Syst Rev. 19;3:CD001257 Jul 2006

Paper

 

Cochrane Review of essential fatty acids for schizophrenia inconclusive but recommends more research needed. Joy C et al, Cochrane Database Syst Rev. 19;3:CD001257 Jul 2006

Details

A Cochrane review is the gold-standard of systematic reviews. This review finds that there are insufficient well-conducted trials, but that there is some evidence of benefit for essential fatty acids in the treatment of schizophrenia. Notably, supplementation of essential fats may reduce the need for psychiatric medication, mental state may improve and that essential fatty acids are well-tolerated. They conclude that “the use of omega-3 polyunsaturated fatty acids for schizophrenia still remains experimental and this review highlights the need for large well designed, conducted and reported studies.”

C B Joy et al., ’Polyunsaturated fatty acid supplementation for schizophrenia’, Cochrane Database Syst Rev. 19;3:CD001257 Jul 2006

Click here for the abstract